HomeCompareAPLT vs VICI

APLT vs VICI: Dividend Comparison 2026

APLT yields 1941.75% · VICI yields 6.57%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 APLT wins by $7549549080.35M in total portfolio value
10 years
APLT
APLT
● Live price
1941.75%
Share price
$0.10
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$7549549081.34M
Annual income
$6,855,073,294,458,854.00
Full APLT calculator →
VICI
VICI Properties Inc.
● Live price
6.57%
Share price
$27.12
Annual div
$1.78
5Y div CAGR
44.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$988.8K
Annual income
$623,261.32
Full VICI calculator →

Portfolio growth — APLT vs VICI

📍 APLT pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodAPLTVICI
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, APLT + VICI cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
APLT pays
VICI pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

APLT
Annual income on $10K today (after 15% tax)
$165,048.54/yr
After 10yr DRIP, annual income (after tax)
$5,826,812,300,290,026.00/yr
VICI
Annual income on $10K today (after 15% tax)
$558.67/yr
After 10yr DRIP, annual income (after tax)
$529,772.12/yr
At 15% tax rate, APLT beats the other by $5,826,812,299,760,254.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of APLT + VICI for your $10,000?

APLT: 50%VICI: 50%
100% VICI50/50100% APLT
Portfolio after 10yr
$3774774541.16M
Annual income
$3,427,536,647,541,057.50/yr
Blended yield
90.80%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on VICI right now

APLT
Analyst Ratings
5
Buy
5
Hold
1
Sell
Consensus: Buy
Price Target
$0.25
+142.7% upside vs current
Range: $0.25 — $0.25
Altman Z
-35.3
Piotroski
1/9
VICI
Analyst Ratings
20
Buy
6
Hold
Consensus: Buy
Price Target
$31.60
+16.5% upside vs current
Range: $30.00 — $33.00
Altman Z
1.4
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

APLT buys
0
VICI buys
0
No recent congressional trades found for APLT or VICI in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricAPLTVICI
Forward yield1941.75%6.57%
Annual dividend / share$2.00$1.78
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%44.3%
Portfolio after 10y$7549549081.34M$988.8K
Annual income after 10y$6,855,073,294,458,854.00$623,261.32
Total dividends collected$7500143229.39M$948.4K
Payment frequencyquarterlyquarterly
SectorStockREIT
Analyst consensusBuyBuy
Analyst price target$0.25$31.60

Year-by-year: APLT vs VICI ($10,000, DRIP)

YearAPLT PortfolioAPLT Income/yrVICI PortfolioVICI Income/yrGap
1← crossover$204,875$194,174.76$11,368$948.43+$193.5KAPLT
2$3,937,114$3,717,897.78$13,339$1,493.16+$3.92MAPLT
3$70,986,064$66,773,352.36$16,326$2,426.21+$70.97MAPLT
4$1,201,115,737$1,125,160,648.71$21,123$4,112.15+$1201.09MAPLT
5$19,077,920,928$17,792,727,089.23$29,379$7,368.23+$19077.89MAPLT
6$284,535,588,112$264,122,212,719.20$44,804$14,191.64+$284535.54MAPLT
7$3,985,969,128,556$3,681,516,049,275.53$76,658$29,972.12+$3985969.05MAPLT
8$52,464,234,462,079$48,199,247,494,524.41$150,894$71,015.81+$52464234.31MAPLT
9$649,042,791,475,683$592,906,060,601,258.60$350,814$193,582.47+$649042791.12MAPLT
10$7,549,549,081,337,835$6,855,073,294,458,854.00$988,809$623,261.32+$7549549080.35MAPLT

APLT vs VICI: Complete Analysis 2026

APLTStock

Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study for the treatment of galactosemia in kids; for treating sorbitol dehydrogenase deficiency; and for the treatment of phosphomannomutase enzyme-CDG. The company also develops AT-001 that is in phase III clinical trials for treating diabetic cardiomyopathy, as well as for the treatment of diabetic peripheral neuropathy. Its preclinical stage products include AT-003 for the treatment diabetic retinopathy; AT-104, a PI3K inhibitor for treating orphan hematological oncology T Cell Acute Lymphoblastic Leukemia. Applied Therapeutics, Inc. was incorporated in 2016 and is headquartered in New York, New York.

Full APLT Calculator →

VICIREIT

VICI Properties is an experiential real estate investment trust that owns one of the largest portfolios of market-leading gaming, hospitality and entertainment destinations, including the world-renowned Caesars Palace. VICI Properties' national, geographically diverse portfolio consists of 29 gaming facilities comprising over 48 million square feet and features approximately 19,200 hotel rooms and more than 200 restaurants, bars and nightclubs. Its properties are leased to industry leading gaming and hospitality operators, including Caesars Entertainment, Inc., Century Casinos Inc., Hard Rock International, JACK Entertainment and Penn National Gaming, Inc. VICI Properties also owns four championship golf courses and 34 acres of undeveloped land adjacent to the Las Vegas Strip. VICI Properties' strategy is to create the nation's highest quality and most productive experiential real estate portfolio.

Full VICI Calculator →
📬

Get this APLT vs VICI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

APLT vs SCHDAPLT vs JEPIAPLT vs OAPLT vs KOAPLT vs MAINAPLT vs NNNAPLT vs EPRTAPLT vs ADC

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.